acute myeloid leukemia

This page shows the latest acute myeloid leukemia news and features for those working in and with pharma, biotech and healthcare.

Astellas’ Xospata scores positive CHMP recommendation

The FLT3 inhibitor received the positive opinion for use as a monotherapy in the treatment of relapsed or refractory acute myeloid leukemia (AML) with FLT3 mutation. ... 2017. AML is the most common form of acute leukaemia in adults and has a low

Latest news

Cellectis gets FDA nod for 'off-the-shelf' CAR-T trial

UCART123 is a gene-edited CAR-T cell therapy that targets CD123 and will be tested in acute myeloid leukemia (AML) and blastic plasmacytoid dendritic cell neoplasm (BPDCN).
Pfizer's SMO inhibitor boosts survival in blood cancer trial

Glasdegib (previously known as PF-04449913) extended overall survival in patients with acute myeloid leukemia (AML) or high-risk myelodysplastic syndrome (MDS) to almost nine months when added to low-dose ... indications such as MDS, acute lymphoblastic
AbbVie and Roche's leukaemia drug venetoclax nears EU market

AbbVie and Roche believe that venetoclax will be effective across a range of blood cancers, and are testing the drug in acute myeloid leukemia, non-Hodgkin's lymphoma, and multiple myeloma
NICE rejects Celgene's Vidaza for leukaemia

The National Institute for Health and Care Excellence (NICE) has turned down Celgene's Vidaza to treat older people with acute myeloid leukemia (AML) in final draft guidance.
Baxalta’s rare blood cancer drug Oncaspar approved in Europe

First EU-wide licence for the acute lymphoblastic leukaemia treatment. Baxalta's aspirations in oncology have received a boost after the European Commission approved Oncaspar, its treatment for a rare form ... Baxalta also plans to investigate Oncaspar

More from news
Approximately 1 fully matching, plus 7 partially matching documents found.

Latest from PMHub

Acute leukaemia patients get new online information centre that will help them get the best possible care

a-kind educational resource centre that provides acute leukaemia patients with the support they need, when they need it most. ... Some of the world's leading experts in the treatment of acute lymphoblastic leukaemia (ALL) and acute myeloid

More from PMHub
Approximately 0 fully matching, plus 1 partially matching documents found.

COVID-19 Updates and Daily News

Featured jobs

Sales Director, Healthcare communications agency, London/ SE UK: Six figure salary

Healthcare Lead Copywriter: Competitive

Medical Editor: Competitive

Healthcare Account Director: Competitive

Account Manager Healthcare / Pharmaceutical Sector: Negotiable Salary

Healthcare Senior Account Manager: Competitive

Account Director – Creative Healthcare Communications: Competative

PMHub

Add my company

Valid Insight

Valid Insight is an award-winning pharmaceutical global market access consultancy....

Latest intelligence

AstraZeneca’s focus on diagnosing and managing chronic kidney disease: People living with chronic kidney disease are in urgent need of new and improved approaches to diagnosis and care...
Delphi Technique Virtual Co-creation: A Customer Story: How a client leveraged the Delphi technique to co-create a consensus statement and algorithm using virtual touchpoints....
Three ways AI will change healthcare in the next decade: Looking forward, there is no doubt that AI will continue to take centre stage in global healthcare initiatives...